NIAID Site Search

This Molecular Genetics Section Protocols document outlines the B. burgdorferi Transposon Mutagenesis.

Last Reviewed: August 6, 2019

This document provides an overview of the NIAID Clinical Research Standards and framework to promote scientifically sound and ethically responsible research.

Last Reviewed: November 25, 2019

This document summarizes the establishment of a long-range physical Master Plan for Rocky Mountain Laboratories in Montana and future development of the campus.

Last Reviewed: December 5, 2019

This document details requirements for Human Subjects Protection and Good Clinical Practice Training for NIAID and Awardee Clinical Research Staff

Last Reviewed: December 2, 2019

This document serves as the Design of a Phase 2 Malaria Vaccine Trial Based on a Cohort Study

Last Reviewed: August 6, 2019

This document provides an overview of the NIAID Research Agenda for Malaria by the Malaria Working Group.

Last Reviewed: August 6, 2019

This document summarizes study of Candida glabrata Murine Invasive Candidiasis and Various groups.

Last Reviewed: August 6, 2019

This document provides background information about the NIAID Ebola Vaccine Antibody Study.

Last Reviewed: August 6, 2019

This Molecular Genetics Section Protocols document outlines the B. burgdorferi mice inoculation.

Last Reviewed: August 6, 2019

This Molecular Genetics Section Protocols document outlines the B. burgdorferi primer sequences.

Last Reviewed: August 6, 2019

This document provides guidelines for the diagnosis and management of food allergy in the US and a summary of the NIAID-sponsored expert panel report.

Last Reviewed: November 26, 2019

This document lists examples of COI and represents the minimum standards for identifying potential COI.

Last Reviewed: August 6, 2019

This document provides an overview of featured technologies which showcase NIAID's timeline for HIV Treatments.

Last Reviewed: August 6, 2019

This document provides a summary of the meeting regarding universal influenza vaccines hosted by NIAID and FDA.

Last Reviewed: August 6, 2019

This document provides examples of leadership plans for single project applications and procedures for resolving conflicts

Last Reviewed: August 6, 2019

The primary objective of this study is to compare the abilities of renal function biomarkers (CysC, CysC-based eGFR equations, SCR, SCREs) relative to iohexol to characterize the PK profiles of meropenem and cefepime in critically ill adult patients with suspected or documented AMR Gram-negative infections.

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in 2006.

Last Reviewed: August 6, 2019

This document provides a progress report for NIAID Biodefense Research Agenda for Category B and C Priority Pathogens.

Last Reviewed: August 6, 2019

This document proposes tests in vaccine trials to compare the vaccine and placebo groups in randomized vaccine trials.

Last Reviewed: August 6, 2019

This document outlines an overview of permutation tests, clustering, asymptotics and provides information about valid inference

Last Reviewed: August 6, 2019

This document is about how all employees of RML are responsible for understanding the environmental and health impacts of their jobs.

Last Reviewed: August 6, 2019

This Molecular Genetics Section Protocols document outlines the B. burgdorferi plating for single colonies or after transformation.

Last Reviewed: August 6, 2019

This document is about Material Transfer Agreement that has been adopted for use by NIH, FDA and CDC.

Last Reviewed: August 6, 2019

This Word document provides a tool for assessing Organization System Reviews and is translated into Chinese.

Last Reviewed: May 25, 2019

This Word document provides a tool for assessing Organization System Reviews and is translated into French.

Last Reviewed: May 25, 2019